![](https://www.biogaiagroup.com/wp-content/uploads/2024/06/peter-rothschild_ceo_biogaia_interim-report.png)
Interview with Peter Rothschild regarding results of Interim report Q2 2013
NewsAugust 26, 2013
Peter Rothschild, CEO of BioGaia, summarizes the second quarter of 2013 and answers to questions regarding the new deal with Nestlé, expectations on the the new distribution agreements in China and South Korea, what it means to be classified as an “orphan drug” by the FDA and also the regulatory progress in Brazil.